Male-Dominated Clinical Trials Have Led to Dangerously Overmedicated Women – ScienceAlert

It’s been 27 years since the United States Food and Drug Administration (FDA) overturned a policy that banned women of childbearing age to be part of clinical trials, but the consequences of such exclusion are still clear to see.
Today, far too many drug prescriptions are based on dosage research conducted on male participants; sometimes, these larger dosages can be dangerous for women and people assigned female at birth.
A new analysis of 86 different drugs, encompassing more than 5,000 artic…

Click here to view the original article.